Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature Review
Crossref DOI link: https://doi.org/10.1007/s13300-019-00681-4
Published Online: 2019-08-24
Published Print: 2019-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Willis, Michael
Asseburg, Christian
Nilsson, Andreas
Neslusan, Cheryl
Funding for this research was provided by:
Janssen Global Services, LLC
Article History
Received: 19 June 2019
First Online: 24 August 2019